[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352872-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352872-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","targeting-oncogenic-lncrna-krt7-as-to-induce-ferroptosis-suppresses-ovarian-cancer-progression","Targeting Oncogenic lncRNA KRT7-AS to Induce Ferroptosis Suppresses Ovarian Cancer Progression","","Ovarian cancer remains the leading cause of death among gynecologic malignancies, and the study investigates how the long non-coding RNA lncRNA KRT7-AS contributes to ovarian tumorigenesis. Bioinformatics analyses identify its clinical significance, while RT-qPCR and fluorescence in situ hybridization assess expression. Functional experiments show that KRT7-AS overexpression promotes proliferation, invasion, and metastasis, whereas knockdown suppresses malignant phenotypes. Mechanistically, KRT7-AS depletion triggers ferroptosis, elevating mitochondrial dysfunction and oxidative stress, increasing lipid peroxidation and Fe2+ accumulation, and altering ferroptosis-related proteins (ACSL4 up, GPX4 down).",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/targeting-oncogenic-lncrna-krt7-as-to-induce-ferroptosis-suppresses-ovarian-cancer-progression/352872/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/targeting-oncogenic-lncrna-krt7-as-to-induce-ferroptosis-suppresses-ovarian-cancer-progression/352872.png","ImageObject",300,407,{"name":42,"@type":43},"Melati","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main purpose of studying lncRNA KRT7-AS in ovarian cancer?","Question",{"text":63,"@type":64},"To clarify the function and regulatory mechanism of lncRNA KRT7-AS in ovarian cancer progression and its connection to ferroptosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does altering KRT7-AS expression affect ovarian cancer cell behavior?",{"text":68,"@type":64},"Overexpression enhances tumorigenic behaviors such as proliferation, invasion, and metastasis, while knockdown suppresses these malignant phenotypes.",{"name":70,"@type":61,"acceptedAnswer":71},"What evidence shows that KRT7-AS knockdown induces ferroptosis?",{"text":72,"@type":64},"KRT7-AS depletion increases mitochondrial membrane potential and reactive oxygen species, promotes lipid peroxidation and Fe2+ accumulation, and the ferroptosis inhibitor ferrostatin-1 reverses the viability reduction.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352872,1790171465,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":99,"preview_page_count":33,"preview_urls":145},962085570644,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Tech Science Press  \n[https://doi. org/10.32604/or.2026.075241](https://doi. org/10.32604/or.2026.075241)  \nARTICLE  \nTargeting Oncogenic lncRNA KRT7-AS to Induce Ferroptosis Suppresses Ovarian Cancer Progression  \nYan Zhu1,\\#, Bin Guan1,\\#, Wencai Guan1, Jihong Zhang1, Shiyu Wang1, Jimin Shi1, Wei Fan1, Qi Lu2,3, Lingyun Zhang4,5, * and Guoxiong Xu1,2, *  \n1 Research Center for Clinical Medicine, Jinshan Hospital, Fudan University, Shanghai, China 2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China 3 Department of Obstetrics and Gynecology, Jinshan Hospital, Fudan University, Shanghai, China 4 Department of Medical Oncology, Shanghai Geriatric Medical Center, Shanghai, China 5 Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China  \n*Corresponding Authors: Lingyun Zhang. Email: [lingyunzhang15@fudan.edu.cn](lingyunzhang15@fudan.edu.cn); Guoxiong Xu. Email: [guoxiong.xu@fudan.edu.cn](guoxiong.xu@fudan.edu.cn)  \n\\# These authors contributed equally to this work  \nReceived: 28 October 2025; Accepted: 26 January 2026; Published: 22 April 2026  \nABSTRACT: Background: Ovarian cancer poses the greatest threat to survival among gynecologic cancers in women. Long non-coding RNAs (lncRNAs) have emerged as critical regulators in oncogenesis. The current study aimed to elucidate the function and regulatory mechanism of lncRNA KRT7-AS in ovarian cancer. Methods: The clinical significance of KRT7-AS was evaluated through bioinformatics analysis of data from public repositories. KRT7-AS expression was examined by RT-qPCR and fluorescence in situ hybridization. The function analyses were conducted using assays for cell proliferation, migration, invasion, wound healing, and colony formation. Assessment of cell cycle and apoptosis was performed using flow cytometry. Mitochondrial membrane potential (MMP), reactive oxygen species (ROS), lipid peroxidation, and ferrous iron (Fe2+) levels were measured with specific kits. Tumor growth was assessed using a xenograft mouse model. Results: Patients exhibiting high KRT7-AS expression had a significantly lower survival rate. Functional assays demonstrated that KRT7-AS overexpression enhanced tumorigenic behaviors, including cell proliferation, invasion, and metastasis, whereas its knockdown suppressed these malignant phenotypes. KRT7-AS depletion induced ferroptosis, as indicated by increased MMP and ROS levels, and the accumulation of lipid peroxidation and Fe2+ . In rescue experiments, the ferroptosis inhibitor ferrostatin-1 reversed the reduction in cell viability caused by KRT7-AS knockdown. Finally, in vivo studies showed that KRT7-AS knockdown inhibited tumor growth and modulated the expression of ferroptosis-related proteins by elevating ACSL4 and reducing GPX4 . Conclusions: These findings suggest that KRT7-AS has potential as a diagnostic biomarker for ovarian cancer. Targeting KRT7-AS to induce ferroptosis may represent a promising therapeutic strategy for suppressing ovarian cancer progression.  \nKEYWORDS: Biomarker; ferroptosis; non-coding RNA; oncogenesis; tumor suppression  \n1 Introduction  \nOvarian cancer, a heterogeneous gynecologic malignancy, is the most lethal disease in women with unfavorable prognoses [1] . With approximately 324,398 new cases diagnosed each year globally in 2022, over 70% of patients have the disease at the advanced stage initially [2] . Current treatment involves cytoreductive surgery followed by platinum-based chemotherapy or interval debulking after neoadjuvant chemotherapy.  \nCopyright © 2026 The Authors. Published by Tech Science Press. This work is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.  \nHowever, approximately 80% of patients experience recurrence and subsequently develop chemoresistance, persistently driving the 5-year survival rate bel","cbCainmAi4w1szSQ","https://ap.wps.com/l/cbCainmAi4w1szSQ","pdf",37914215,24,"English","# Abstract\n# Introduction\n## Background and clinical challenge\n## Regulated cell death and ferroptosis\n## Roles of GPX4 and ACSL4\n## lncRNAs in cancer and cell death pathways","[{\"question\":\"What was the main purpose of studying lncRNA KRT7-AS in ovarian cancer?\",\"answer\":\"To clarify the function and regulatory mechanism of lncRNA KRT7-AS in ovarian cancer progression and its connection to ferroptosis.\"},{\"question\":\"How does altering KRT7-AS expression affect ovarian cancer cell behavior?\",\"answer\":\"Overexpression enhances tumorigenic behaviors such as proliferation, invasion, and metastasis, while knockdown suppresses these malignant phenotypes.\"},{\"question\":\"What evidence shows that KRT7-AS knockdown induces ferroptosis?\",\"answer\":\"KRT7-AS depletion increases mitochondrial membrane potential and reactive oxygen species, promotes lipid peroxidation and Fe2+ accumulation, and the ferroptosis inhibitor ferrostatin-1 reverses the viability reduction.\"}]","Targeting Oncogenic lncRNA KRT7-AS to Induce Ferroptosis Suppresses Ovarian Cancer Progression | PDF",1790101820,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99cd62d63b87b9cb041c89149f3891ec.webp",983,1271,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aed9a8dfa24df18c3b85d8b6168da23a.webp",982,1270,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3ce8e3358cffced0db9c91ba568fdb13.webp",981,1269,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16edf042b10572d0e33e81099ff2e6b7.webp",980,1267]